blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0755408

EP0755408 - PEPTIDES FOR REDUCING OR INHIBITING BONE RESORPTION, ANGIOGENESIS AND RESTENOSIS [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  27.10.2006
Database last updated on 16.11.2024
Most recent event   Tooltip27.10.2006Refusal of applicationpublished on 29.11.2006  [2006/48]
Applicant(s)For all designated states
LA JOLLA CANCER RESEARCH FOUNDATION
10901 North Torrey Pines Road
La Jolla, CA 92037 / US
[1997/05]
Inventor(s)01 / CHENG, Soan
10936 Elderwood Road
San Diego, CA 92131 / US
02 / INGRAM, Ronald
4935 Elderwood Road
San Diego, CA 92131 / US
03 / MULLEN, Daniel
Apartment 130 860 Turquoise
San Diego, CA 92109 / US
04 / TSCHOPP, Juerg
12668 Intermezzo Way
San Diego, CA 92130 / US
[1997/05]
Representative(s)Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
[N/P]
Former [1997/05]UEXKÜLL & STOLBERG
Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Application number, filing date95917573.812.04.1995
[1997/05]
WO1995US04741
Priority number, dateUS1994022731613.04.1994         Original published format: US 227316
US1994030305208.09.1994         Original published format: US 303052
[1997/05]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9528426
Date:26.10.1995
[1995/46]
Type: A1 Application with search report 
No.:EP0755408
Date:29.01.1997
Language:EN
The application published by WIPO in one of the EPO official languages on 26.10.1995 takes the place of the publication of the European patent application.
[1997/05]
Search report(s)International search report - published on:EP14.12.1995
ClassificationIPC:C07K14/75, C07K14/78, A61K38/36, A61K38/39
[1997/05]
CPC:
C07K5/1019 (EP,US); A61P3/02 (EP); A61P43/00 (EP);
A61P9/10 (EP); C07K14/75 (EP,US); C07K14/78 (EP,US);
A61K38/00 (EP,US) (-)
Designated contracting statesBE,   CH,   DE,   DK,   FR,   GB,   IT,   LI,   NL,   SE [1997/05]
TitleGerman:PEPTIDE ZUR VERRINGERUNG ODER VERMEIDUNG VON KNOCHENRESORPTION ANGIOGENESE UND RESTENOSE[1997/05]
English:PEPTIDES FOR REDUCING OR INHIBITING BONE RESORPTION, ANGIOGENESIS AND RESTENOSIS[1997/05]
French:PEPTIDE LIMITANT OU EMPECHANT LA RESORPTION OSSEUSE, L'ANGIOGENESE ET LA RESTENOSE[1997/05]
Entry into regional phase08.11.1996National basic fee paid 
08.11.1996Designation fee(s) paid 
08.11.1996Examination fee paid 
Examination procedure10.11.1995Request for preliminary examination filed
International Preliminary Examining Authority: EP
08.11.1996Examination requested  [1997/05]
23.10.1997Despatch of a communication from the examining division (Time limit: M06)
06.08.1998Reply to a communication from the examining division
11.10.1999Despatch of a communication from the examining division (Time limit: M06)
13.04.2000Reply to a communication from the examining division
24.09.2001Despatch of a communication from the examining division (Time limit: M06)
21.03.2002Reply to a communication from the examining division
13.05.2004Despatch of a communication from the examining division (Time limit: M06)
29.12.2004Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
08.03.2005Reply to a communication from the examining division
07.12.2005Date of oral proceedings
07.07.2006Despatch of communication that the application is refused, reason: substantive examination [2006/48]
17.07.2006Application refused, date of legal effect [2006/48]
Divisional application(s)EP98250297.3  / EP0896003
Request for further processing for:08.03.2005Request for further processing filed
08.03.2005Full payment received (date of receipt of payment)
Request granted
23.03.2005Decision despatched
06.08.1998Request for further processing filed
06.08.1998Full payment received (date of receipt of payment)
Request granted
24.08.1998Decision despatched
Fees paidRenewal fee
12.04.1997Renewal fee patent year 03
14.04.1998Renewal fee patent year 04
14.04.1999Renewal fee patent year 05
27.04.2000Renewal fee patent year 06
12.04.2001Renewal fee patent year 07
12.04.2002Renewal fee patent year 08
14.04.2003Renewal fee patent year 09
29.04.2004Renewal fee patent year 10
13.04.2005Renewal fee patent year 11
17.03.2006Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]EP0425212  (SMITHKLINE BEECHAM CORP [US]) [X] 1-85 * page 5, line 58 - page 6, line 9 * * page 13, line 46 - page 14, line 58; example -; claim - *;
 [X]WO9115515  (JOLLA CANCER RES FOUND [US]) [X] 1-85 * example 4; claim -; table - *;
 [X]WO9200995  (TANABE SEIYAKU CO [JP]) [X] 1-85 * page 5, line 8 - line 12 * * page 7, line 11 - line 20; example -; claim - *;
 [X]EP0578083  (MERCK PATENT GMBH [DE]) [X] 1-85 * page 3, line 50 - line 54; example -; claim - *;
 [PX]EP0618225  (MERCK PATENT GMBH [DE]) [PX] 1-85 * page 2, line 25 - line 35; example -; claim - *;
 [PX]WO9500544  (JOLLA CANCER RES FOUND [US], et al) [PX] 1-85 * example 3; claim - *;
 [E]WO9514714  (JOLLA CANCER RES FOUND [US]) [E] 1-85 * page 4, line 1 - line 27; example -; claim - *;
 [X]  - E.T. CHOI ET AL., "Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA", JOURNAL OF VASCULAR SURGERY, vol. 19, no. 1, pages 125 - 134 [X] 1-85 * page 125, column L, paragraph 1 * * page 131, column L, paragraph 2 - page 133, column L, paragraph 2 *
 [X]  - FAUCHERE J -L ET AL, "MODULATION OF THE ACTIVITY AND ASSESSMENT OF THE RECEPTOR SELECTIVITY IN A SERIES OF NEW RGD-CONTAINING PEPTIDES", INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, (19931101), vol. 42, no. 5, pages 440 - 444, XP000399941 [X] 1-85 * page 444, column L, paragraph 2 - column R, paragraph 1 *
 [A]  - AUMAILLEY M ET AL, "ARG-GLY-ASP CONSTRAINED WITHIN CYCLIC PENTAPEPTIDES STRONG AND SELECTIVE INHIBITORS OF CELL ADHESION TO VITRONECTIN AND LAMININ FRAGMENT PL", FEBS LETTERS, (19911007), vol. 291, no. 1, pages 50 - 54, XP000225814 [A] 1-85 * page 51, column R, paragraph 3; table 1 *

DOI:   http://dx.doi.org/10.1016/0014-5793(91)81101-D
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.